Results 61 to 70 of about 98,054 (191)

Preferences, needs and QALYs. [PDF]

Journal of Medical Ethics, 1996
Quality Adjusted Life Years (QALYs) have become a household word among health economists. Their use as a means of comparing the value of health programmes and medical interventions has stirred up controversy in the medical profession and the academic community.
openaire   +3 more sources

Lifetime QALY prioritarianism in priority setting: quantification of the inherent trade-off

Cost Effectiveness and Resource Allocation, 2014
BackgroundMultiple principles are relevant in priority setting, two of which are often considered particularly important. According to the greater benefit principle, resources should be directed toward the intervention with the greater health benefit ...
Trygve Ottersen, Ottar Mæstad, O. Norheim   +2 more
semanticscholar   +1 more source

WTP for a QALY and health states: More money for severer health states?

Cost Effectiveness and Resource Allocation, 2013
BackgroundIn economic evaluation, cost per quality-adjusted life year (QALY) is generally used as an indicator for cost-effectiveness. Although JPY 5 million to 6 million (USD 60, 000 to 75,000) per QALY is frequently referred to as a threshold in Japan,
T. Shiroiwa, A. Igarashi, T. Fukuda, S. Ikeda   +3 more
semanticscholar   +1 more source

QALY: Quality Adjusted Life Year

Medicine Science, 2012
Nufusun yaslanmasi ve yaslilik donemi hastaliklar ile kronik hastaliklarin one cikmasi verilen saglik hizmetlerinin sadece saglik duzeyi uzerine degil yasam kalitesine etkisinin de onemli bir cikti olarak degerlendirilmesini getirmistir.
Selale Sahin, Selime Toprak, Erdinc Unal
doaj   +1 more source

COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES

Фармакоэкономика, 2015
a total of 62 patients with a diagnosis of low back pain. Low back pain patients were randomized of two group. Patients of the first (main) group received a course of intraosseous blockades, while patients of the second (control group) received a course ...
M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova   +3 more
doaj  

Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis

Health Technology Assessment
Background Renal cell carcinoma is the most common type of kidney cancer, comprising approximately 85% of all renal malignancies. Patients with advanced renal cell carcinoma are the focus of this National Institute for Health and Care Excellence multiple
Nigel Fleeman, Rachel Houten, Sarah Nevitt, James Mahon, Sophie Beale, Angela Boland, Janette Greenhalgh, Katherine Edwards, Michelle Maden, Devarshi Bhattacharyya, Marty Chaplin, Joanne McEntee, Shien Chow, Tom Waddell   +13 more
doaj   +1 more source

Фармакоэкономический анализ использования лираглутида в составе комбинированной терапии в лечении сахарного диабета 2-го типа

Фармакоэкономика, 2015
The analysis goal is to determine the cost-effectiveness of liraglutideas add-on to metformin in for patients with type 2 diabetes in condition of the Russian health care system.
A. Yu. Kulikov, I. V. Novikov
doaj  

Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation

Health Technology Assessment, 2013
Background: Dementia is one of the most common and serious disorders in later life and the economic and personal cost of caring for people with dementia is immense. There is a need to be able to evaluate interventions in dementia using cost-effectiveness
B Mulhern, D Rowen, J Brazier, S Smith, R Romeo, R Tait, C Watchurst, K-C Chua, V Loftus, T Young, D Lamping, M Knapp, R Howard, S Banerjee   +13 more
doaj   +1 more source

Cost-effectiveness analysis of robotic-arm assisted versus manual total knee arthroplasty in the UK

Bone & Joint Open
Aims: The aim of this study was to estimate the additional cost per quality-adjusted life-year (QALY) of robotic-assisted total knee arthroplasty (rTKA) compared to manually performed total knee arthroplasty (mTKA).
Gurdeep S. Sagoo, Nick D. Clement, Yaneth Gil-Rojas, Nawaraj Bhattarai, Steven Galloway, Jenny B. Baron, Karen Smith, David J. Weir, David J. Deehan   +8 more
doaj   +1 more source

Оценка качества жизни, связанного со здоровьем

Качественная клиническая практика, 2018
Исследование качества жизни, связанного со здоровьем, является новой современной методологией здравоохранения, позволяющей оценить результаты лечения больных, дополняя традиционные методики.

doaj